Table 1.
Potentially inappropriate medications (PIMs) first prescribed during hospitalization and then continued at discharge and at one month
| PIMs prescribed during hospitalization (818/1,267a) | PIMs prescribed during hospitalization and at discharge (40/818) | PIMs prescribed during hospitalization, at discharge, and at one-month post-discharge (21/818) | ||||
|---|---|---|---|---|---|---|
| N | (%) | N | (%) | N | (%) | |
| TOTAL | 818 | (64.6) | 40 | (4.9) | 21 | (2.6) |
| Dexketoprofen | 209 | (16.5) | 5 | (0.6) | 0 | (0.0) |
| Midazolam | 202 | (15.9) | 0 | (0.0) | 0 | (0.0) |
| Diazepam | 78 | (6.2) | 6 | (0.7) | 2 | (0.2) |
| Doxazosin | 67 | (5.3) | 11 | (1.3) | 6 | (0.7) |
| Pethidine (meperidine) | 59 | (4.7) | 0 | (0.0) | 0 | (0.0) |
| Alprazolam | 40 | (3.2) | 1 | (0.1) | 1 | (0.1) |
| Clorazepate | 31 | (2.4) | 2 | (0.2) | 0 | (0.0) |
| Clonazepam | 27 | (2.1) | 8 | (1.0) | 7 | (0.9) |
| Paraffin | 25 | (2.0) | 1 | (0.1) | 1 | (0.1) |
| Zolpidem | 21 | (1.7) | 3 | (0.4) | 3 | (0.4) |
| Bromazepam | 18 | (1.4) | 0 | (0.0) | 0 | (0.0) |
| Diclofenac | 13 | (1.0) | 0 | (0.0) | 0 | (0.0) |
| Indomethacin | 6 | (0.5) | 0 | (0.0) | 0 | (0.0) |
| Fluoxetine | 5 | (0.4) | 0 | (0.0) | 0 | (0.0) |
| Paroxetine | 5 | (0.4) | 3 | (0.4) | 1 | (0.1) |
| Nifedipine | 4 | (0.3) | 0 | (0.0) | 0 | (0.0) |
| Clobazam | 2 | (0.2) | 0 | (0.0) | 0 | (0.0) |
| Pentoxifylline | 2 | (0.2) | 0 | (0.0) | 0 | (0.0) |
| Clonidine | 1 | (0.1) | 0 | (0.0) | 0 | (0.0) |
| Phenobarbital | 1 | (0.1) | 0 | (0.0) | 0 | (0.0) |
| Medazepam with amitriptyline | 1 | (0.1) | 0 | (0.0) | 0 | (0.0) |
| Prasugrel | 1 | (0.1) | 0 | (0.0) | 0 | (0.0) |
a Data available from 14 of the 16 participating hospitals